Candriam Equities L Oncology Impact SF2 Fonds
1.080,21
EUR
+12,09
EUR
+1,13
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 6,45% |
| Merck & Co Inc | US58933Y1055 | 4,89% |
| Novo Nordisk AS Class B | DK0062498333 | 4,45% |
| Roche Holding AG | CH0012032048 | 4,40% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,10% |
| Thermo Fisher Scientific Inc | US8835561023 | 3,94% |
| Amgen Inc | US0311621009 | 3,87% |
| AstraZeneca PLC | GB0009895292 | 3,73% |
| Hologic Inc | US4364401012 | 3,63% |
| Gilead Sciences Inc | US3755581036 | 3,49% |
| Sonstige | 57,06% |